Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells.
BMC Cancer
; 20(1): 332, 2020 Apr 19.
Article
in En
| MEDLINE
| ID: mdl-32306906
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gene Expression Regulation, Neoplastic
/
Carcinoma, Hepatocellular
/
Cyclin-Dependent Kinase 4
/
Cyclin-Dependent Kinase 6
/
Sirtuin 3
/
Sorafenib
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2020
Type:
Article
Affiliation country:
South Korea